调心汤对冠心病PCI围手术期焦虑临床观察  

Clinical Observation of Tiaoxintang on Perioperative Anxiety in Patients Treated With PCI

作　　者：梁田 张庆 

机构地区：[1]徐州市中医院,江苏徐州221009

出　　处：《深圳中西医结合杂志》2016年第7期44-46,共3页Shenzhen Journal of Integrated Traditional Chinese and Western Medicine

摘　　要：目的:研究冠心病患者接受经皮冠状动脉介入治疗(PCI)围手术期焦虑状况,观察其疗效及安全性。方法:将68例冠心病行PCI术患者,予以术前及术后焦虑自评量表(SAS)评分,并将患者随机分为治疗组和对照组各34例,两组均接受常规治疗和PCI术,治疗组同时口服调心汤125 m L,采用SAS评分和临床资料调查表等,于治疗前后5 d进行评估分析。结果:治疗组患者手术成功率与对照组相同,治疗组焦虑明显缓解,差异具有统计学意义(P<0.05),治疗组患者临床疗效好于对照组,但差异无统计学意义(P>0.05),无明显并发症。结论:冠心病PCI围手术期患者使用中药调心汤,抗焦虑明显,可改善患者心绞痛症状,无明显副作用。Objective To study perioperative anxiety in patients with coronary heart disease（CHD）before and after the PCI therapy, and to investigate the clinical efficacy and security of Chinese medicine tiaoxintang in the treatment of perioperative anxiety in patients treated with PCI. Methods 68 patients with CHD were investigated and assessed with SAS before and after the operation of PCI, 68 cases were randomly divided into treatment group（n=34） and control group（n=34）. Both groups received routine therapy and PCI, but the patients in the treatment group received tiaoxintang orl 125 ml bid, SAS was used to evaluate the patients for 5 days before and after therapy. Results Two groups are anxiety seriously before the operation. After therapy, compared with the control group, the SAS quantity value of treatment group have marked difference（P 0.05）. The clinical efficacy of treatment group is better than control group. The complications between two groups have no significant difference. Conclusion Traditional Chinese medicine tiaoxintang is an effective medicine to reduce the anxiety in patients with CHD who receive the PCI, and improve patient＇s clinical efficacy, it has no insignificant side efficacy.

关 键 词：冠心病 经皮冠状动脉介入治疗 围手术期焦虑 

分 类 号：R541.4[医药卫生—心血管疾病]